Pliant Therapeutics Inc (PLRX)

Finanzdaten der Pliant Therapeutics Inc-Aktie (PLRX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	9.60%23.86	21.77	23.58	28.27	45.59
Research and Development	23.14%16.73	13.58	15.59	17.94	32.20
Operating Income/Loss	9.60%-23.86	-21.77	-23.58	-28.27	-45.59
Income Tax Expense/Benefit	-	-	-	-	-
	11.63%-22.37	-20.04	-23.58	-26.30	-43.30
Attributable To Parent	11.63%-22.37	-20.04	-23.58	-26.30	-43.30
Basic Average Shares	0.19%61.92	61.80	-	61.41	61.39
Diluted Average Shares	0.19%61.92	61.80	-	61.41	61.39
Basic Earnings Per Share	12.50%-0.36	-0.32	-	-0.43	-0.71
Diluted Earnings Per Share	12.50%-0.36	-0.32	-	-0.43	-0.71
Common Stock Dividends	-	-	-	-	-